<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20105" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Creatine Phosphokinase</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aujla</surname>
            <given-names>Ravinder S.</given-names>
          </name>
          <aff>Kasturba Medical College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Roshan</given-names>
          </name>
          <aff>University of Central Florida</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ravinder Aujla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Roshan Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20105.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Creatine phosphokinase (CPK), also known as creatine kinase (CK), is the enzyme that catalyzes&#x000a0;the reaction of creatine and adenosine triphosphate (ATP) to phosphocreatine (PCr) and adenosine diphosphate (ADP).<xref ref-type="bibr" rid="article-20105.r1">[1]</xref>&#x000a0;This&#x000a0;CK enzyme reaction is reversible; ATP can be generated from PCr and ADP. The phosphocreatine created from this reaction is used to supply tissues and cells that require substantial amounts of ATP, like the brain, skeletal muscles, and the heart.<xref ref-type="bibr" rid="article-20105.r2">[2]</xref>&#x000a0;CK is a central&#x000a0;regulator of cellular energy homeostasis. Many conditions can cause derangement in&#x000a0;CK levels, including rhabdomyolysis, heart disease, kidney disease, or medications.<xref ref-type="bibr" rid="article-20105.r3">[3]</xref>&#x000a0;As such, it is a diagnostic indicator for specifically rhabdomyolysis and acute myocardial infarction (AMI), among other medical disorders.</p>
      </sec>
      <sec id="article-20105.s2" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Creatine&#x000a0;kinase (CK)&#x000a0;is a compact enzyme of around 82&#x02009;kDa found in both the cytosol and mitochondria of tissues with high energy demands.<xref ref-type="bibr" rid="article-20105.r4">[4]</xref> In the cytosol,&#x000a0;CK comprises&#x000a0;2 polypeptide subunits of around 42&#x02009;kDa, and&#x000a0;2&#x000a0;subunits are found: M (muscle type) and B (brain type).<xref ref-type="bibr" rid="article-20105.r5">[5]</xref> The genes for these subunits are located on different chromosomes:&#x000a0;B&#x000a0;on 14q32 and&#x000a0;M&#x000a0;on 19q13. These subunits allow the formation of&#x000a0;3 tissue-specific isoenzymes: CPK-MB (cardiac muscle), CPK-MM (skeletal muscle), and CPK-BB (brain).</p>
        <p>Typically, the ratio of subunits varies with muscle type: skeletal muscle (98% MM&#x000a0;to 2% MB), cardiac muscle (70% to 80%&#x02009;MM and 20%&#x000a0;to 30%&#x02009;MB), while the brain predominantly has the isoenzyme BB.<xref ref-type="bibr" rid="article-20105.r6">[6]</xref>&#x000a0;In mitochondria, 2 specific forms of CK exist: Mt-CK, a non-sarcomeric type called ubiquitous Mt-CK expressed in various tissues such as the brain, smooth muscle, and sperm, and a sarcomeric Mt-CK expressed in cardiac and skeletal muscle. The mitochondrial CK isoform is an octamer consisting of&#x000a0;4 dimers each.<xref ref-type="bibr" rid="article-20105.r7">[7]</xref> While mitochondrial&#x000a0;CK is directly involved in forming&#x000a0;PCr&#x000a0;from mitochondrial ATP, cytosolic CK regenerates ATP from ADP using PCr. This happens at intracellular sites where ATP is used in the cell, with CK acting as an in situ&#x000a0;ATP regenerator.</p>
        <p>Mt-CK and cytosolic CK are connected in a so-called PCr/Cr-shuttle or circuit.<xref ref-type="bibr" rid="article-20105.r8">[8]</xref>&#x000a0;PCr generated by Mt-CK in mitochondria is shuttled to cytosolic CK that is coupled to ATP-dependent processes, eg, ATPases, such as actomyosin ATPase and calcium ATPase involved in muscle contraction, and sodium/potassium ATPase involved in sodium retention in the kidney.<xref ref-type="bibr" rid="article-20105.r9">[9]</xref> The bound cytosolic CK accepts PCr shuttled through the cell and uses ADP to regenerate ATP, which the ATPases use as an energy source (CK is associated with the ATPases, forming a coupled microcompartment).<xref ref-type="bibr" rid="article-20105.r10">[10]</xref>&#x000a0;PCr is a buffer and transporter between subcellular sites of energy production (mitochondria and glycolysis) and energy utilization (ATPases).<xref ref-type="bibr" rid="article-20105.r11">[11]</xref></p>
        <p>Typically,&#x000a0;CK is available in heart tissue, skeletal muscles, the brain, etc. However, upon muscular injury, leakage of&#x000a0;CK into the bloodstream occurs. Thus,&#x000a0;CK is indicative of muscular damage. CPK-MB is a more specific indicator of myocardial muscle damage, while CPK-MM is more indicative of skeletal muscle damage.<xref ref-type="bibr" rid="article-20105.r12">[12]</xref>&#x000a0;CK activity in the serum of healthy people is almost exclusively due to MM activity (though small amounts of CPK-MB may be present)&#x000a0;due to&#x000a0;the physiological turnover of muscle tissue.<xref ref-type="bibr" rid="article-20105.r13">[13]</xref></p>
        <p>When electrophoresed, CPK-MM runs closest to the cathode, CPK-MB has intermediate mobility, and CPK-BB moves farthest from the point of application toward the anode. Mt-CK, which runs more cathodal than the MM fraction, is usually associated with tissue necrosis that accompanies severe anoxic shock and liver disease.<xref ref-type="bibr" rid="article-20105.r14">[14]</xref> CK activity&#x000a0;is also&#x000a0;found in a macromolecular form&#x02014;the so-called macro-CK. Macro-CK is transiently found in sera of up to 6% of hospitalized patients, but only a small proportion of these have increased CK activities in serum.<xref ref-type="bibr" rid="article-20105.r15">[15]</xref>&#x000a0;The enzyme&#x000a0;exists in&#x000a0;2 forms, types 1 and 2. Macro-CK type 1 is a complex of CK, typically CK-BB, and an immunoglobulin,&#x000a0;commonly IgG.<xref ref-type="bibr" rid="article-20105.r16">[16]</xref>&#x000a0;Macro-CK type 1 is&#x000a0;usually&#x000a0;seen in women aged older than 50. Macro-CK type 2 is oligomeric Mt-CK found in severely ill adults with malignancies or children with tissue distress.<xref ref-type="bibr" rid="article-20105.r17">[17]</xref></p>
        <p>Both M and B subunits have a C-terminal lysine residue, but only the former is hydrolyzed by the action of carboxypeptidases present in the blood. Carboxypeptidases B or N&#x000a0;sequentially hydrolyze the lysine residues from CKMM to produce&#x000a0;2 CK-MM isoforms&#x02014;CK-MM2 (1 lysine residue removed) and CK-MM1 (both lysine residues removed).<xref ref-type="bibr" rid="article-20105.r18">[18]</xref></p>
        <p>The loss of positively charged lysine produces a more negatively charged CK molecule with greater anodic mobility at electrophoresis. Because CK-MB has only&#x000a0;1 M subunit, the dimer coded by the M and B genes is CK-MB2, and the lysine-hydrolyzed dimer is CK-MB1. The assay of the CK isoforms requires special techniques, such as high-voltage electrophoresis (with gel cooling), HPLC, chromatofocusing, or immunoassay.<xref ref-type="bibr" rid="article-20105.r19">[19]</xref></p>
      </sec>
      <sec id="article-20105.s3" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>Specimens for CK analysis include serum and plasma heparin. Other than heparin, anticoagulants should not be used in collection tubes because they inhibit CK activity. The collection of specimens in gel separator tubes does not appear to affect CK activity compared to tubes&#x000a0;without gel.<xref ref-type="bibr" rid="article-20105.r20">[20]</xref>&#x000a0;CK activity in serum is relatively unstable and lost during storage. Average stabilities are less than 8 hours at room temperature, 48 hours at 4 &#x000ba;C, and&#x000a0;1 month at &#x02212;20 &#x000ba;C.<xref ref-type="bibr" rid="article-20105.r21">[21]</xref> Therefore, the serum specimen should be stored at &#x02212;80 C&#x000ba; if the analysis is delayed for more than 30 days.&#x000a0;</p>
        <p>Since less risk of&#x000a0;hemolysis is present, fresh serum is the preferred specimen for analysis of the CK isoenzyme pattern.<xref ref-type="bibr" rid="article-20105.r22">[22]</xref>&#x000a0;Of the&#x000a0;3 commonly seen isoenzymes, CK-BB activity is the least stable. Adding a thiol such as 2-mercaptoethanol to the serum improves its stability. CK-MB activity is not significantly reduced when the separated serum is stored for up to 48 hours at 4 &#x000ba;C or&#x000a0;1 month at &#x02212;20 &#x000ba;C.&#x000a0;Since the mass measurement is not subject to the loss of enzymatic activity, CK-MB protein concentration in serum is stable for weeks when the specimen is stored under refrigeration and for several years if stored at &#x02212;20 &#x000ba;C.<xref ref-type="bibr" rid="article-20105.r23">[23]</xref></p>
      </sec>
      <sec id="article-20105.s4" sec-type="Testing Procedures">
        <title>Testing Procedures</title>
        <p>Numerous photometric, fluorometric, and coupled-enzyme methods have been developed for the assay of CK activity, using either the forward (Cr&#x000a0;--&#x0003e; CRP) or the reverse (Cr&#x000a0;&#x0003c;-- CRP) reaction.<xref ref-type="bibr" rid="article-20105.r24">[24]</xref> All commercial assays for total CK are based on the reverse reaction that proceeds about&#x000a0;6 times faster than the forward reaction. The ATP produced is measured by hexokinase (HK) or glucose-6-phosphate dehydrogenase (G6PD) coupled reactions that convert NADP+ to NADPH, monitored spectrophotometrically at 340 nm.<xref ref-type="bibr" rid="article-20105.r4">[4]</xref>&#x000a0;The increase in absorbance is a measure of CK activity present in the specimen.</p>
        <p>Electrophoresis and various immunological methods are commonly used to analyze CK isoenzyme.<xref ref-type="bibr" rid="article-20105.r25">[25]</xref> Electrophoretic methods help separate all of the CK isoenzymes. The isoenzyme bands are visualized by incubating the support (eg, agarose or cellulose acetate) with a concentrated CK assay mixture using the reverse reaction.</p>
        <p>The NADPH formed in this reaction is detected by observing the bluish-white fluorescence after excitation by long-wave (360 nm) ultraviolet light. NADPH may be quantified by fluorescence densitometry, which detects bands of 2 to 5 U/L. The mobility of CK isoenzymes at pH 8.6 toward the anode is BB &#x0003e; MB &#x0003e; MM, with the MM remaining cathodic to the point of application.<xref ref-type="bibr" rid="article-20105.r26">[26]</xref> The discriminating power of electrophoresis also allows the detection of abnormal CK bands (eg, macro-CK). The disadvantages of electrophoresis include the long turnaround time,&#x000a0;labor intensity, incompatibility with clinical chemistry analyzers in emergencies, and required interpretative skills.<xref ref-type="bibr" rid="article-20105.r27">[27]</xref></p>
        <p>Immunochemical methods apply to the direct measurement of CK-MB. In the immunoinhibition technique, an anti-CK-M subunit antiserum is used to inhibit both M subunits of CK-MM and the single M subunit of CK-MB, determining the enzyme activity of the B subunit of CK-MB, the B subunits of CK-BB, and macro-CKs. This technique assumes the absence of CK-BB (and other sources of interference such as macro-CKs) from the tested serum to determine CK-MB.<xref ref-type="bibr" rid="article-20105.r28">[28]</xref> Because the CK-B subunit accounts for half the CK-MB activity, the change in absorbance should be doubled to obtain the measure of CK-MB activity. This results in a significant decrease in the analytical sensitivity of the method. If present, atypical macro-CK may result in falsely elevated CK-MB results. Owing to its low sensitivity and specificity, the immunoinhibition technique&#x000a0;is supplanted mainly by mass assays of CK-MB.<xref ref-type="bibr" rid="article-20105.r29">[29]</xref></p>
        <p>In contrast with immunoinhibition, which measures the CK-MB isoenzyme by determination of its catalytic activity, mass immunoassays measure CK-MB protein concentrations.<xref ref-type="bibr" rid="article-20105.r30">[30]</xref>&#x000a0;Several mass assays using various labels are now commercially available and used for routine CK-MB determination. Measurements use the &#x0201c;sandwich&#x0201d; technique,&#x000a0;where&#x000a0;the antibody specifically recognizes the MB dimer. The sandwich technique ensures that only CK-MB is estimated because neither CK-MM nor CK-BB reacts with both antibodies. Mass assays are more sensitive than activity-based methods, with a detection limit for CK-MB usually &#x0003c;1 &#x003bc;g/L.<xref ref-type="bibr" rid="article-20105.r31">[31]</xref>&#x000a0;Other advantages include sample stability, noninterference with hemolysis, drugs, or other catalytic activity inhibitors, full automation, and fast turnaround time.<xref ref-type="bibr" rid="article-20105.r32">[32]</xref></p>
      </sec>
      <sec id="article-20105.s5" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>A moderate degree of hemolysis (up to 0.32 g/dL of hemoglobin) does not significantly influence the measured CK activity because erythrocytes contain no CK activity.<xref ref-type="bibr" rid="article-20105.r33">[33]</xref> However, severely hemolyzed specimens are unsatisfactory because enzymes and intermediates (AK, ATP, and glucose-6-phosphate) liberated from the erythrocytes may affect the lag phase and the side reactions in the assay system. Turbid and icteric samples can be analyzed; appropriate values are obtained if the starting absorbance is not too high.<xref ref-type="bibr" rid="article-20105.r34">[34]</xref></p>
      </sec>
      <sec id="article-20105.s6" sec-type="Results, Reporting, and Critical Findings&#x0000d;&#x0000a;">
        <title>Results, Reporting, and Critical Findings
</title>
        <p>Serum CK activity is subject to physiological variations. Sex, age, muscle mass, physical activity, and race all interact to affect measured serum activity. Males generally have a larger muscle mass,&#x000a0;correlating to&#x000a0;higher serum CK activities than females. The racial type also affects CK activities; the mean activity in white individuals is 66% of the activity in black individuals.<xref ref-type="bibr" rid="article-20105.r34">[34]</xref> In white subjects, the reference interval is 46 to 171 U/L for males and&#x000a0;34 to 145 U/L for females when measured with an assay traceable to the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) 37 C reference procedure.</p>
        <p>Newborns generally have higher CK activities resulting from skeletal muscle trauma during birth. Serum CK in infants decreases to the adult reference interval by 6 to 10 weeks. CK-BB may be elevated in neonates, particularly in newborns with brain-damaged or low birth weight.<xref ref-type="bibr" rid="article-20105.r35">[35]</xref>&#x000a0;The presence of CK-BB in blood, usually at low concentrations, may represent a physiological finding in the first days of life. The suggested upper reference limits when standardized methods for CK determination are employed are males up to 170 U/L and females up to 145 U/L.&#x000a0;With the CK-MB mass assay, the upper reference limit for males is 5.0 &#x003bc;g/L, and the value for females is lower. However, many laboratories use&#x000a0;the male reference interval.<xref ref-type="bibr" rid="article-20105.r36">[36]</xref></p>
        <p>In populations who frequently exercise, such as well-trained, long-distance runners, the CK-MB content of skeletal muscle increases, which may produce abnormal serum CK-MB concentrations to separate non-myocardial infarction from myocardial infarction patients; a &#x0201c;relative index&#x0201d; (RI) is necessary.<xref ref-type="bibr" rid="article-20105.r37">[37]</xref>&#x000a0;The RI relates CK-MB mass concentration in &#x003bc;g/L to measured total CK activity in U/L.<xref ref-type="bibr" rid="article-20105.r38">[38]</xref> Results are expressed as a percentage: physiological: &#x02264;3%, equivocal: 3% to 5%, consistent with myocardial necrosis: &#x0003e;5%.<xref ref-type="bibr" rid="article-20105.r39">[39]</xref>&#x000a0;Blood sampling between 8 and 36 hours from symptom onset is necessary to use the RI.</p>
      </sec>
      <sec id="article-20105.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>CK activity is one of the markers of AMI.<xref ref-type="bibr" rid="article-20105.r40">[40]</xref>&#x000a0;The&#x000a0;activity rises within 12 hours of AMI symptoms, peaks at 24 to 36 hours, and normalizes after 48 to 72 hours (see <bold>Image.&#x000a0;</bold>Creatine Kinase Levels After a Myocardial Infarction). The issue with measuring&#x000a0;CK activity for AMI is that it is&#x000a0;non-specific to the heart. CK activity can increase in several conditions, such as rhabdomyolysis, chronic muscle diseases, burns, and strenuous exercise.<xref ref-type="bibr" rid="article-20105.r41">[41]</xref>&#x000a0;Although the CK-MB measurement is a diagnostic improvement over just CK,&#x000a0;the enzyme can still increase in other conditions such as acute muscle injury, congestive cardiac failure, and arrhythmias.<xref ref-type="bibr" rid="article-20105.r42">[42]</xref></p>
        <p>Elevated CK-MB levels have&#x000a0;long indicated the diagnosis of&#x000a0;AMI. Although many centers are&#x000a0;utilizing troponin levels instead of CK-MB, a newer, more specific CK-MB analysis method is used.<xref ref-type="bibr" rid="article-20105.r43">[43]</xref> The new testing method involves measuring the values of the CK-MB1 and CK-MB2 isoforms. In a normal patient, the ratio of CK-MB2 to CK-MB1 should be 1&#x000a0;to 1. In the case of AMI, the ratio&#x000a0;peaks within 4 hours of the infarction. However, some evidence of AMI can be detected as early as 1 to 2 hours after the infarction.<xref ref-type="bibr" rid="article-20105.r44">[44]</xref> To diagnose AMI, the ratio of CK-MB2 to CK-MB1 should be greater than 1.7 to 1. However, a ratio greater than or equal to 1.5 to 1 strongly indicates&#x000a0;AMI.&#x000a0;Additional cardiac conditions&#x000a0;that increase serum CK and CK-MB in the serum are&#x000a0;coronary artery bypass surgery, cardiac transplantation, myocarditis, and pulmonary embolism.<xref ref-type="bibr" rid="article-20105.r45">[45]</xref>&#x000a0;Serum CK activity is significantly elevated in all types of muscular dystrophy.<xref ref-type="bibr" rid="article-20105.r46">[46]</xref>&#x000a0;In Duchenne sex-linked muscular dystrophy, enzyme activity is highest in childhood and may be elevated long before clinical signs appear, especially during infancy (7 to 10 years of age).</p>
        <p>Serum CK activity&#x000a0;decreases as patients age, and the mass of functioning muscles diminishes with the progression of the disease. About 50% to 80% of the asymptomatic female carriers of Duchenne dystrophy show threefold to sixfold increases in CK activity.<xref ref-type="bibr" rid="article-20105.r47">[47]</xref><xref ref-type="bibr" rid="article-20105.r48">[48]</xref>&#x000a0;High CK values are noted in viral myositis, polymyositis, and similar muscle diseases. However, serum enzyme activity is not increased in neurogenic muscle diseases like myasthenia gravis, multiple sclerosis, poliomyelitis, and parkinsonism.<xref ref-type="bibr" rid="article-20105.r49">[49]</xref> Patients with Alzheimer disease and Pick disease may have decreased&#x000a0;CK activity in the brain. The BB-CK activity is primarily decreased in these patients, resulting in an overall decrease in total&#x000a0;CK activity.<xref ref-type="bibr" rid="article-20105.r50">[50]</xref></p>
        <p>CK&#x000a0;levels also&#x000a0;rise in patients with rhabdomyolysis.<xref ref-type="bibr" rid="article-20105.r51">[51]</xref>&#x000a0;Rhabdomyolysis may result from a crush injury, drug use, viral infections, and strenuous exercise.&#x000a0;The condition typically presents with muscle pain, weakness, and dark-colored urine.&#x000a0;A breakdown of skeletal muscle is usually seen, releasing CK, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and electrolytes.<xref ref-type="bibr" rid="article-20105.r52">[52]</xref> The reason for the dark urine is due to myoglobinuria. A&#x000a0;CK level that increases to more than 1000 IU/L indicates rhabdomyolysis; values over 5000 IU/L indicate severe rhabdomyolysis.</p>
        <p>Patients with sickle cell trait who start a new strenuous exercise program such as spin class are also at an increased risk of rhabdomyolysis, with reported&#x000a0;CK levels higher than 70000 IU/L in some cases.<xref ref-type="bibr" rid="article-20105.r53">[53]</xref>&#x000a0;The most common complication resulting from rhabdomyolysis is acute kidney injury.<xref ref-type="bibr" rid="article-20105.r54">[54]</xref>&#x000a0;Any patient with suspected rhabdomyolysis should receive prompt treatment with&#x000a0;IV fluids to preserve kidney function.<xref ref-type="bibr" rid="article-20105.r55">[55]</xref></p>
        <p>Patients on statins such as simvastatin may have an adverse effect of significantly elevated&#x000a0;CK levels, potentially leading to rhabdomyolysis.<xref ref-type="bibr" rid="article-20105.r56">[56]</xref>&#x000a0;This risk increases if the patient takes a drug that inhibits cytochrome P450-3A4 (CYP3A4).<xref ref-type="bibr" rid="article-20105.r57">[57]</xref> Some common medications to avoid in patients on statin therapy include clarithromycin, erythromycin, verapamil, tamoxifen, and antifungal agents.<xref ref-type="bibr" rid="article-20105.r56">[56]</xref></p>
        <p>Low levels of&#x000a0;CK can be present in patients with connective tissue diseases such as rheumatoid arthritis or systemic lupus erythematosus. Low levels may be seen in patients with reduced physical activity, such as elderly bedridden patients.<xref ref-type="bibr" rid="article-20105.r58">[58]</xref> A low level of serum CK is associated with an increased risk of death in a CKD population.<xref ref-type="bibr" rid="article-20105.r59">[59]</xref>&#x000a0;A&#x000a0;CK before the start of peritoneal dialysis between 111 and 179 IU/L is associated with a lower risk of death.<xref ref-type="bibr" rid="article-20105.r60">[60]</xref></p>
        <p>Serum CK activity demonstrates an inverse relationship with thyroid activity. About 60% of hypothyroid subjects show an average elevation of CK activity fivefold more than the upper reference limit.<xref ref-type="bibr" rid="article-20105.r61">[61]</xref>&#x000a0;The major isoenzyme is CK-MM, suggesting muscular involvement. In subclinical hypothyroidism,&#x000a0;some degree of dysfunction is evident in skeletal muscle metabolism.<xref ref-type="bibr" rid="article-20105.r62">[62]</xref><xref ref-type="bibr" rid="article-20105.r63">[63]</xref></p>
        <p>Strenuous, prolonged exercise results in large increases in serum CK.<xref ref-type="bibr" rid="article-20105.r64">[64]</xref> In untrained persons, serum CK appears to increase proportionately to the duration and intensity of the exercise; however, conditioned persons show smaller changes. Sustained exercise increases the CK-MB content of skeletal muscle, owing to the phenomenon of &#x0201c;fetal reversion,&#x0201d;&#x000a0;where fetal patterns of protein synthesis reappear.<xref ref-type="bibr" rid="article-20105.r65">[65]</xref><xref ref-type="bibr" rid="article-20105.r66">[66]</xref> Thus, serum CK-MB isoenzyme may increase in such circumstances. This explanation may also account for the elevated CK-MB values sometimes observed in chronic renal failure (uremic myopathy).<xref ref-type="bibr" rid="article-20105.r67">[67]</xref></p>
        <p>Plasma&#x000a0;CK&#x000a0;activity is significantly associated with blood pressure in the general population and is thought to contribute to hypertension by increasing vascular contractility and renal sodium retention.<xref ref-type="bibr" rid="article-20105.r68">[68]</xref><xref ref-type="bibr" rid="article-20105.r69">[69]</xref> Similar to the association in the general population, plasma&#x000a0;CK activity measured in early&#x000a0;pregnancy&#x000a0;is associated with blood pressure during&#x000a0;pregnancy.<xref ref-type="bibr" rid="article-20105.r70">[70]</xref>&#x000a0;Plasma CK activity is also associated with severe gestational hypertension diagnosed before 34 weeks of gestation but not with preeclampsia&#x000a0;or HELLP, which&#x000a0;suggests differences in pathophysiology.<xref ref-type="bibr" rid="article-20105.r71">[71]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20105.s8" sec-type="Quality Control and Lab Safety&#x0000d;&#x0000a;">
        <title>Quality Control and Lab Safety
</title>
        <p>A quality management system (QMS) is essential for laboratory tests to ensure accuracy, reliability, and timeliness. Poor QMS can lead to unwarranted treatment or complications, delayed diagnoses, and unnecessary follow-up, among other consequences.<xref ref-type="bibr" rid="article-20105.r72">[72]</xref>&#x000a0;A QMS framework provides the laboratory with a set of essential building blocks, including well-defined objectives, standards, and procedures concerning quality management, employee training, education, calibration, maintenance of lab equipment, raw material or test sample handling, instrumentation and control processes, laboratory safety, and records management and reporting.<xref ref-type="bibr" rid="article-20105.r73">[73]</xref> Neglecting these elements can compromise the laboratory quality management system (LQMS), leading to&#x000a0;inaccurate&#x000a0;laboratory results, barriers to regulatory compliance, and&#x000a0;lowered customer expectations.<xref ref-type="bibr" rid="article-20105.r74">[74]</xref></p>
        <p>Quality control (QC), often called internal quality control, involves continuously monitoring a measurement procedure to ensure that results obtained from patient samples adhere to performance criteria suitable for patient care.<xref ref-type="bibr" rid="article-20105.r75">[75]</xref>&#x000a0;QC plays a crucial role in recognizing and addressing any error conditions. When the result of a QC material falls within acceptable limits of the expected value,&#x000a0;this confirms the stability and functioning of the measurement procedure, enabling a higher confidence level in reporting patient sample results.</p>
        <p>Conversely, suppose a QC result falls outside the acceptable limits. In that case, the QC result&#x000a0;signals a potential malfunction in the measurement procedure, indicating a likelihood that patient sample results might not be suitable for clinical use, necessitating corrective measures.<xref ref-type="bibr" rid="article-20105.r76">[76]</xref> In cases where corrective action is required, patient sample measurements should be re-evaluated&#x000a0;when the measurement procedure has been restored to ensure stable and accurate performance. When erroneous results have been reported before identifying the error condition, issuing a corrected report&#x000a0;is necessary.</p>
        <p>The quality control materials are measured&#x000a0;periodically along with patient samples.<xref ref-type="bibr" rid="article-20105.r77">[77]</xref> For non-waived tests, laboratory regulations require, at the minimum, analysis of at least&#x000a0;2 levels of control materials every 24 hours. Laboratories can assay QC samples more frequently to ensure accurate results. Quality control samples should be assayed after calibration or maintenance of an analyzer to verify the correct method performance.<xref ref-type="bibr" rid="article-20105.r78">[78]</xref>&#x000a0;To reduce the frequency of quality control (QC) when conducting tests that require fewer checks than those mandated by regulatory agencies (eg, monthly), laboratories can create an Individualized Quality Control Plan (IQCP). This involves conducting a risk assessment of all potential sources of error throughout the testing process and implementing a QC plan to minimize the likelihood of errors.<xref ref-type="bibr" rid="article-20105.r79">[79]</xref>&#x000a0;</p>
        <p>The Levey-Jennings plot is the most commonly used format for evaluating QC results.<xref ref-type="bibr" rid="article-20105.r80">[80]</xref> This format presents each QC result chronologically, offering a quick visual means to evaluate performance. When the measurement procedure adheres to stable conditions per specifications, the mean value is the targeted or expected value for the QC result. Concurrently, the standard deviation (SD) lines illustrate the expected level of imprecision. Under the assumption of a Gaussian (normal) distribution of imprecision, the results should demonstrate an even distribution around the mean, with occurrences more frequently observed closer to the mean than at the distribution's extremes.<xref ref-type="bibr" rid="article-20105.r81">[81]</xref>&#x000a0;Westgard multi-rules are used to evaluate the quality control runs. In case of any rule violation, proper corrective and preventive action should be&#x000a0;enforced before patient testing.&#x000a0; &#x000a0;&#x000a0;</p>
        <p>Laboratories are required to participate in external quality control or proficiency testing (PT) programs as mandated by the Centers for Medicare and Medicaid Services (CMS) in the Clinical Laboratory Improvement Amendments (CLIA) regulations.<xref ref-type="bibr" rid="article-20105.r82">[82]</xref> Participating in the PT program is beneficial as&#x000a0;this guarantees the precision and reliability of the laboratory's results compared to other labs conducting similar assays. CMS and voluntary accreditation organizations oversee mandatory participation and results evaluation.&#x000a0;The PT plan should be included in the quality assessment (QA) plan and the laboratory's overall quality program.<xref ref-type="bibr" rid="article-20105.r83">[83]</xref></p>
        <p>Every clinical laboratory should establish and uphold a formal safety program as its top priority. This program forms the foundation for ensuring patients' and laboratory staff's safety and well-being.&#x000a0;The program provides a structured framework for recognizing, lessening, and controlling potential hazards linked with laboratory activities. The laboratory significantly diminishes the chances of errors, incidents, and exposure to unsafe materials through strict adherence to safety protocols.<xref ref-type="bibr" rid="article-20105.r84">[84]</xref></p>
        <p>Protective barriers, such as gloves, masks, protective eyewear, and gowns, must be employed when collecting patient specimens. Disposable gloves from nonsterile latex or alternative materials offering adequate barrier protection should be utilized. Phlebotomists must change gloves when moving between&#x000a0;blood draws from different patients. Additionally,&#x000a0;hand hygiene protocols are important when&#x000a0;gloves are changed.<xref ref-type="bibr" rid="article-20105.r85">[85]</xref>&#x000a0;Lab technicians should wear facial protection and protective clothing to minimize the risk of exposure to blood or bodily fluids. They should also minimize syringe use and dispose of needles safely in rigid containers. After leaving the lab, they should remove all protective gear.<xref ref-type="bibr" rid="article-20105.r86">[86]</xref></p>
        <p>According to OSHA regulations, employees at risk of exposure should be offered the hepatitis B vaccine as part of their regular or occasional duties. Per the CDC's Advisory Committee on Immunization Practices, medical technologists, phlebotomists, and pathologists are recommended to receive the hepatitis B vaccine. Consequently, the obligation is to provide, at the very least, these laboratory employees with the choice to accept the hepatitis B vaccine at no cost.<xref ref-type="bibr" rid="article-20105.r87">[87]</xref></p>
      </sec>
      <sec id="article-20105.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Creatine phosphokinase (CPK) or creatine kinase (CK) is essential in diagnosing acute rhabdomyolysis&#x000a0;or AMI and chronic conditions such as sickle cell disease. As such, several clinicians may provide their diagnostic interpretation of an individual patient. An interprofessional team consisting of a nephrologist, surgeon, and nurse may manage the condition in a patient who presents with rhabdomyolysis after an increased CK level. The nephrologist&#x000a0;strives to improve kidney function in such patients, as acute kidney injury is the most common complication of rhabdomyolysis. The surgeon may need to surgically repair any damaged muscle or tissue that leads to the condition. The nurse should teach the patient about managing their condition and avoiding&#x000a0;exacerbating or triggering rhabdomyolysis.</p>
        <p>The healthcare team can consult with the pharmacist to verify that any patient's medications are not potential sources for elevated CK.<xref ref-type="bibr" rid="article-20105.r88">[88]</xref>&#x000a0;Any hospital staff working in the emergency department should know that intravenous fluid therapy&#x000a0;is started promptly to curb acute kidney injury in patients with suspected rhabdomyolysis.<xref ref-type="bibr" rid="article-20105.r89">[89]</xref></p>
      </sec>
      <sec id="article-20105.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20105&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20105">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20105/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20105">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20105.s11">
        <fig id="article-20105.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Creatine Kinase Levels After a Myocardial Infarction. Creatine kinase levels after myocardial infarction are compared to levels of myoglobin and troponin. Contributed by&#x000a0;O Chaigasame, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Creatine__kinase" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20105.s12">
        <title>References</title>
        <ref id="article-20105.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moghadam-Kia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oddis</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Approach to asymptomatic creatine kinase elevation.</article-title>
            <source>Cleve Clin J Med</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">26760521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLeish</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kenyon</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Relating structure to mechanism in creatine kinase.</article-title>
            <source>Crit Rev Biochem Mol Biol</source>
            <year>2005</year>
            <season>Jan-Feb</season>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-20</page-range>
            <pub-id pub-id-type="pmid">15804623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morandi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Prelle</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grassi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Politano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Grandis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cudia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Citterio</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm.</article-title>
            <source>Neurol Sci</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>303</fpage>
            <page-range>303-11</page-range>
            <pub-id pub-id-type="pmid">17122938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takagi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yasuhara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gomi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Creatine kinase and its isozymes].</article-title>
            <source>Rinsho Byori</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>Suppl 116</volume>
            <fpage>52</fpage>
            <page-range>52-61</page-range>
            <pub-id pub-id-type="pmid">11797380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heels-Ansdell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hiralal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>McQueen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McFalls</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Filipovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;nemann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sear</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Foex</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Landesberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Godet</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Poldermans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bursi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kertai</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Devereaux</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis.</article-title>
            <source>Anesthesiology</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>796</fpage>
            <page-range>796-806</page-range>
            <pub-id pub-id-type="pmid">21336095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takemura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Inagaki</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mihara</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kokudo</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Elevation in creatine kinase isoenzyme-MM associated with hepatocellular carcinoma: a case report and review of literature.</article-title>
            <source>Clin J Gastroenterol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>460</fpage>
            <page-range>460-466</page-range>
            <pub-id pub-id-type="pmid">35199319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlattner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tokarska-Schlattner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wallimann</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial creatine kinase in human health and disease.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>1762</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-80</page-range>
            <pub-id pub-id-type="pmid">16236486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keceli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sourdon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gabr</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sch&#x000e4;r</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tocchetti</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Stuber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agrimi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Leppo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Steenbergen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yanek</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>O'Rourke</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gerstenblith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bottomley</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Paolocci</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.</article-title>
            <source>Circ Res</source>
            <year>2022</year>
            <month>Mar</month>
            <day>04</day>
            <volume>130</volume>
            <issue>5</issue>
            <fpage>741</fpage>
            <page-range>741-759</page-range>
            <pub-id pub-id-type="pmid">35109669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wendt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wallimann</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage.</article-title>
            <source>Biol Signals Recept</source>
            <year>2001</year>
            <season>Jan-Apr</season>
            <volume>10</volume>
            <issue>1-2</issue>
            <fpage>93</fpage>
            <page-range>93-111</page-range>
            <pub-id pub-id-type="pmid">11223643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlattner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tokarska-Schlattner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial Proteolipid Complexes of Creatine Kinase.</article-title>
            <source>Subcell Biochem</source>
            <year>2018</year>
            <volume>87</volume>
            <fpage>365</fpage>
            <page-range>365-408</page-range>
            <pub-id pub-id-type="pmid">29464567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlattner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tokarska-Schlattner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Br&#x000fc;ckner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Polge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Epand</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Lacombe</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Epand</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial kinases and their molecular interaction with cardiolipin.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>1788</volume>
            <issue>10</issue>
            <fpage>2032</fpage>
            <page-range>2032-47</page-range>
            <pub-id pub-id-type="pmid">19409873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panteghini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serum isoforms of creatine kinase isoenzymes.</article-title>
            <source>Clin Biochem</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>211</fpage>
            <page-range>211-8</page-range>
            <pub-id pub-id-type="pmid">3044646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallimann</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tokarska-Schlattner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schlattner</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>The creatine kinase system and pleiotropic effects of creatine.</article-title>
            <source>Amino Acids</source>
            <year>2011</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>1271</fpage>
            <page-range>1271-96</page-range>
            <pub-id pub-id-type="pmid">21448658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chattington</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Neithercut</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase isoform electrophoresis for the early confirmation of myocardial infarction detected by timed sequential CK slope analysis.</article-title>
            <source>Postgrad Med J</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>70</volume>
            <issue>829</issue>
            <fpage>805</fpage>
            <page-range>805-8</page-range>
            <pub-id pub-id-type="pmid">7824414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyness</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Hunsaker</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>La'ulu</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Detection of macro-creatine kinase and macroamylase by polyethylene glycol precipitation and ultrafiltration methods.</article-title>
            <source>Clin Chim Acta</source>
            <year>2011</year>
            <month>Nov</month>
            <day>20</day>
            <volume>412</volume>
            <issue>23-24</issue>
            <fpage>2052</fpage>
            <page-range>2052-7</page-range>
            <pub-id pub-id-type="pmid">21276785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davidson</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Detection of creatine kinase macroenzymes.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>Pt 5</issue>
            <fpage>482</fpage>
            <page-range>482-5</page-range>
            <pub-id pub-id-type="pmid">22896659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eidizadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>von Ahsen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Friedewald</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Macro-CK type 2 in metastatic prostate cancer.</article-title>
            <source>Diagnosis (Berl)</source>
            <year>2019</year>
            <month>Aug</month>
            <day>27</day>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>307</fpage>
            <page-range>307-309</page-range>
            <pub-id pub-id-type="pmid">30412465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>ZJ</given-names>
              </name>
            </person-group>
            <article-title>Structure of human muscle creatine kinase.</article-title>
            <source>Acta Crystallogr D Biol Crystallogr</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>Pt 8</issue>
            <fpage>1196</fpage>
            <page-range>1196-200</page-range>
            <pub-id pub-id-type="pmid">11517911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schumann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bonora</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ceriotti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Clerc-Renaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ferrero</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>F&#x000e9;rard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Franck</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Gella</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Hoelzel</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>J&#x000f8;rgensen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kanno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kessne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klauker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kristiansen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lessinger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Linsinger</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Misaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Panteghini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pauwels</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schimmel</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Vialle</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weidemann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Siekmann</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>635</fpage>
            <page-range>635-42</page-range>
            <pub-id pub-id-type="pmid">12211662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>von Meyer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cadamuro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simundic</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Blood sample quality.</article-title>
            <source>Diagnosis (Berl)</source>
            <year>2019</year>
            <month>Mar</month>
            <day>26</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-31</page-range>
            <pub-id pub-id-type="pmid">29794250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giavarina</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Blood venous sample collection: Recommendations overview and a checklist to improve quality.</article-title>
            <source>Clin Biochem</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>50</volume>
            <issue>10-11</issue>
            <fpage>568</fpage>
            <page-range>568-573</page-range>
            <pub-id pub-id-type="pmid">28242283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simundic</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cadamuro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Costelloe</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Managing hemolyzed samples in clinical laboratories.</article-title>
            <source>Crit Rev Clin Lab Sci</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-21</page-range>
            <pub-id pub-id-type="pmid">31603708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vivekanandan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Swaminathan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinically effective CK-MB reporting: how to do it?</article-title>
            <source>J Postgrad Med</source>
            <year>2010</year>
            <season>Jul-Sep</season>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>226</fpage>
            <page-range>226-8</page-range>
            <pub-id pub-id-type="pmid">20739777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Recommended method for the determination of creatine kinase in blood.</article-title>
            <source>Scand J Clin Lab Invest</source>
            <year>1976</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>711</fpage>
            <page-range>711-23</page-range>
            <pub-id pub-id-type="pmid">1031483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanemitsu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Okigaki</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase isoenzymes.</article-title>
            <source>J Chromatogr</source>
            <year>1988</year>
            <month>Jul</month>
            <day>29</day>
            <volume>429</volume>
            <fpage>399</fpage>
            <page-range>399-417</page-range>
            <pub-id pub-id-type="pmid">3062028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Differentiation of creatine kinase MB and IgA-linked BB isoenzymes on electrophoresis.</article-title>
            <source>FEBS Lett</source>
            <year>1987</year>
            <month>Apr</month>
            <day>06</day>
            <volume>214</volume>
            <issue>1</issue>
            <fpage>192</fpage>
            <page-range>192-4</page-range>
            <pub-id pub-id-type="pmid">3494633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogunro</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Hearse</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Shillingford</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase isoenzymes: their separation and quantitation.</article-title>
            <source>Cardiovasc Res</source>
            <year>1977</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-102</page-range>
            <pub-id pub-id-type="pmid">870200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laurino</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fischberg-Bender</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Galligan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An immunochemical mass assay for the direct measurement of creatine kinase MB2.</article-title>
            <source>Ann Clin Lab Sci</source>
            <year>1995</year>
            <season>May-Jun</season>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-63</page-range>
            <pub-id pub-id-type="pmid">7605108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Christenson</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Murakami</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Apple</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.</article-title>
            <source>Clin Chim Acta</source>
            <year>2004</year>
            <month>Aug</month>
            <day>16</day>
            <volume>346</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-9</page-range>
            <pub-id pub-id-type="pmid">15256323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marwah</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Trivedi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haridas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Mass Versus Activity of Creatine Kinase MB and Its Utility in the Early Diagnosis of Re-infarction.</article-title>
            <source>Indian J Clin Biochem</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-6</page-range>
            <pub-id pub-id-type="pmid">24757297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miyazaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furuno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nonogi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Haze</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hiramori</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level.</article-title>
            <source>Jpn Heart J</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>717</fpage>
            <page-range>717-27</page-range>
            <pub-id pub-id-type="pmid">8164339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Obzansky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lott</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Clinical evaluation of an immunoinhibition procedure for creatine kinase-MB.</article-title>
            <source>Clin Chem</source>
            <year>1980</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>150</fpage>
            <page-range>150-2</page-range>
            <pub-id pub-id-type="pmid">7356551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salvagno</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Montagnana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brocco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guidi</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Influence of hemolysis on routine clinical chemistry testing.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2006</year>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>311</fpage>
            <page-range>311-6</page-range>
            <pub-id pub-id-type="pmid">16519604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hedayati</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Razavi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Boroomand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kheradmand Kia</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The impact of pre-analytical variations on biochemical analytes stability: A systematic review.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>e23551</fpage>
            <pub-id pub-id-type="pmid">32869910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Timonen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lloyd-Puryear</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hougaard</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Meri&#x000f6;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>M&#x000e4;kinen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Laitala</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>P&#x000f6;l&#x000f6;nen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Skogstrand</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Airenne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Polari</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Korpim&#x000e4;ki</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP<sup>&#x000ae;</sup> Neonatal Creatine Kinase-MM Kit in a US and Danish Population.</article-title>
            <source>Int J Neonatal Screen</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>27</fpage>
            <pub-id pub-id-type="pmid">33072986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaninotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mion</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Novello</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Delprete</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moretti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Creatine-kinase MB mass: age and sex-associated reference limits in two different platforms that use the same method.</article-title>
            <source>Clin Chim Acta</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>401</volume>
            <issue>1-2</issue>
            <fpage>162</fpage>
            <page-range>162-4</page-range>
            <pub-id pub-id-type="pmid">19101529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>St&#x000e4;ubli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roessler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>K&#x000f6;chli</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Peheim</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Straub</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase and creatine kinase MB in endurance runners and in patients with myocardial infarction.</article-title>
            <source>Eur J Appl Physiol Occup Physiol</source>
            <year>1985</year>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-5</page-range>
            <pub-id pub-id-type="pmid">4018053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>el Allaf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chapelle</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>el Allaf</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Faymonville</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Heusghem</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio.</article-title>
            <source>Clin Chem</source>
            <year>1986</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>291</fpage>
            <page-range>291-5</page-range>
            <pub-id pub-id-type="pmid">3510780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lindberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dubin</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Three rapid immunoassays for the determination of creatine kinase MB: an analytical, clinical, and interpretive evaluation.</article-title>
            <source>Am Heart J</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>122</volume>
            <issue>4 Pt 1</issue>
            <fpage>958</fpage>
            <page-range>958-64</page-range>
            <pub-id pub-id-type="pmid">1927882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bleifeld</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Buss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hanrath</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase release in acute myocardial infarction: correlation with clinical, electrocardiographic, and pathological findings.</article-title>
            <source>Br Heart J</source>
            <year>1975</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>1161</fpage>
            <page-range>1161-8</page-range>
            <pub-id pub-id-type="pmid">1191432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apple</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic use of CK-MM and CK-MB isoforms for detecting myocardial infarction.</article-title>
            <source>Clin Lab Med</source>
            <year>1989</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>643</fpage>
            <page-range>643-54</page-range>
            <pub-id pub-id-type="pmid">2686906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tricoci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leonardi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither?</article-title>
            <source>MLO Med Lab Obs</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14, 16</page-range>
            <pub-id pub-id-type="pmid">26281113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadoh</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Eregie</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Nwaneri</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Sadoh</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>The diagnostic value of both troponin T and creatinine kinase isoenzyme (CK-MB) in detecting combined renal and myocardial injuries in asphyxiated infants.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>e91338</fpage>
            <pub-id pub-id-type="pmid">24625749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puleo</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wathen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tawa</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hamburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Obermueller</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Triana</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>Sep</month>
            <day>01</day>
            <volume>331</volume>
            <issue>9</issue>
            <fpage>561</fpage>
            <page-range>561-6</page-range>
            <pub-id pub-id-type="pmid">7702648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaitman</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Cyr</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Bangalore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boden</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Demkow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piero Perna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Riezebos</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>McFalls</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bagai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gosselin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rockhold</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Waters</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Thygesen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Maron</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Hochman</surname>
                <given-names>JS</given-names>
              </name>
              <collab>ISCHEMIA Research Group</collab>
            </person-group>
            <article-title>Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.</article-title>
            <source>Circulation</source>
            <year>2021</year>
            <month>Feb</month>
            <day>23</day>
            <volume>143</volume>
            <issue>8</issue>
            <fpage>790</fpage>
            <page-range>790-804</page-range>
            <pub-id pub-id-type="pmid">33267610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ke</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Griggs</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gatheridge</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing.</article-title>
            <source>Biomed Res Int</source>
            <year>2020</year>
            <volume>2020</volume>
            <fpage>8396429</fpage>
            <pub-id pub-id-type="pmid">33029525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Carrier screening model for Duchenne muscular dystrophy for women of reproductive age based on a pre-pregnancy birth defect control platform].</article-title>
            <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>
            <year>2021</year>
            <month>May</month>
            <day>10</day>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>485</fpage>
            <page-range>485-487</page-range>
            <pub-id pub-id-type="pmid">33974262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gatheridge</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mendell</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Scheuerbrandt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moat</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Eyskens</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rockman-Greenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Drousiotou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Griggs</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.</article-title>
            <source>JAMA Neurol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-6</page-range>
            <pub-id pub-id-type="pmid">26594870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tokunaga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taniguchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Misaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shimomura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nishino</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takeshima</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Underlying diseases in sporadic presentation of high creatine kinase levels in girls.</article-title>
            <source>Clin Chim Acta</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>519</volume>
            <fpage>198</fpage>
            <page-range>198-203</page-range>
            <pub-id pub-id-type="pmid">33965408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finsterer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>St&#x000f6;llberger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Krugluger</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Significance of CK-elevation in noncompaction with regard to cardiac and neuromuscular disease.</article-title>
            <source>Int J Cardiol</source>
            <year>2008</year>
            <month>Nov</month>
            <day>12</day>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>174</fpage>
            <page-range>174-9</page-range>
            <pub-id pub-id-type="pmid">18055044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>FY</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: a review of the literature.</article-title>
            <source>Neth J Med</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>9</issue>
            <fpage>272</fpage>
            <page-range>272-83</page-range>
            <pub-id pub-id-type="pmid">19841484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatzizisis</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Misirli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hatzitolios</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Giannoglou</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>The syndrome of rhabdomyolysis: complications and treatment.</article-title>
            <source>Eur J Intern Med</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>568</fpage>
            <page-range>568-74</page-range>
            <pub-id pub-id-type="pmid">19046720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sauret</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Marinides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis.</article-title>
            <source>Am Fam Physician</source>
            <year>2002</year>
            <month>Mar</month>
            <day>01</day>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>907</fpage>
            <page-range>907-12</page-range>
            <pub-id pub-id-type="pmid">11898964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bratteb&#x000f8;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fredriksen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wisborg</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Prevention of acute renal failure in muscular injuries].</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>1992</year>
            <month>Aug</month>
            <day>10</day>
            <volume>112</volume>
            <issue>18</issue>
            <fpage>2370</fpage>
            <page-range>2370-2</page-range>
            <pub-id pub-id-type="pmid">1412240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altintepe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guney</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tonbul</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>T&#x000fc;rk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mazi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>A&#x0011f;ca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yeksan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Early and intensive fluid replacement prevents acute renal failure in the crush cases associated with spontaneous collapse of an apartment in Konya.</article-title>
            <source>Ren Fail</source>
            <year>2007</year>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>737</fpage>
            <page-range>737-41</page-range>
            <pub-id pub-id-type="pmid">17763170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Staa</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>O'Meara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McCann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pirmohamed</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>649</fpage>
            <page-range>649-59</page-range>
            <pub-id pub-id-type="pmid">24602118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mogyor&#x000f3;si</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Showalter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schubert</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin.</article-title>
            <source>J Intern Med</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>246</volume>
            <issue>6</issue>
            <fpage>599</fpage>
            <page-range>599-602</page-range>
            <pub-id pub-id-type="pmid">10620105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pavlidis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsokos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elin</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Plotz</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of low creatine phosphokinase values in patients with connective tissue diseases.</article-title>
            <source>JAMA</source>
            <year>1981</year>
            <month>Oct</month>
            <day>23-30</day>
            <volume>246</volume>
            <issue>17</issue>
            <fpage>1921</fpage>
            <page-range>1921-3</page-range>
            <pub-id pub-id-type="pmid">7288967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flahault</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Metzger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chass&#x000e9;</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Haymann</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Boffa</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Flamant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vrtovsnik</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Houillier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stengel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thervet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pallet</surname>
                <given-names>N</given-names>
              </name>
              <collab>NephroTest study group</collab>
            </person-group>
            <article-title>Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e0156433</fpage>
            <pub-id pub-id-type="pmid">27248151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Creatine Kinase and Mortality in Peritoneal Dialysis.</article-title>
            <source>Front Cardiovasc Med</source>
            <year>2022</year>
            <volume>9</volume>
            <fpage>855891</fpage>
            <pub-id pub-id-type="pmid">35620514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGrowder</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Rawlins</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Serum creatine kinase and lactate dehydrogenase activities in patients with thyroid disorders.</article-title>
            <source>Niger J Clin Pract</source>
            <year>2011</year>
            <season>Oct-Dec</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>454</fpage>
            <page-range>454-9</page-range>
            <pub-id pub-id-type="pmid">22248949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beyer</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Karmali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Demeester-Mirkine</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cogan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fuss</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Serum creatine kinase levels in overt and subclinical hypothyroidism.</article-title>
            <source>Thyroid</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>8</volume>
            <issue>11</issue>
            <fpage>1029</fpage>
            <page-range>1029-31</page-range>
            <pub-id pub-id-type="pmid">9848718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hekimsoy</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Oktem</surname>
                <given-names>IK</given-names>
              </name>
            </person-group>
            <article-title>Serum creatine kinase levels in overt and subclinical hypothyroidism.</article-title>
            <source>Endocr Res</source>
            <year>2005</year>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-5</page-range>
            <pub-id pub-id-type="pmid">16392619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koch</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The creatine kinase response to resistance exercise.</article-title>
            <source>J Musculoskelet Neuronal Interact</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-77</page-range>
            <pub-id pub-id-type="pmid">24583542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brancaccio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maffulli</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Limongelli</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase monitoring in sport medicine.</article-title>
            <source>Br Med Bull</source>
            <year>2007</year>
            <volume>81-82</volume>
            <fpage>209</fpage>
            <page-range>209-30</page-range>
            <pub-id pub-id-type="pmid">17569697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedersen</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Tengesdal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Radtke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Langlo</surname>
                <given-names>KAR</given-names>
              </name>
            </person-group>
            <article-title>Major increase in creatine kinase after intensive exercise.</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>2019</year>
            <month>Apr</month>
            <day>09</day>
            <volume>139</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">30969059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caravaca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gonzales</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bayo</surname>
                <given-names>M&#x000c1;</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Musculoskeletal pain in patients with chronic kidney disease.</article-title>
            <source>Nefrologia</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>433</fpage>
            <page-range>433-40</page-range>
            <pub-id pub-id-type="pmid">27267921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brewster</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Mairuhu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bindraban</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Koopmans</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>van Montfrans</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase activity is associated with blood pressure.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Nov</month>
            <day>07</day>
            <volume>114</volume>
            <issue>19</issue>
            <fpage>2034</fpage>
            <page-range>2034-9</page-range>
            <pub-id pub-id-type="pmid">17075013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnsen</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lilleng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wilsgaard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bekkelund</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase activity and blood pressure in a normal population: the Troms&#x000f8; study.</article-title>
            <source>J Hypertens</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-42</page-range>
            <pub-id pub-id-type="pmid">21063205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horjus</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bokslag</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hutten</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>van den Born</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vrijkotte</surname>
                <given-names>TGM</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase is associated with blood pressure during pregnancy.</article-title>
            <source>J Hypertens</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>1467</fpage>
            <page-range>1467-1474</page-range>
            <pub-id pub-id-type="pmid">31145714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horjus</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bokslag</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hooijberg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hutten</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>CJM</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase and blood pressure in women with a history of early-onset preeclampsia.</article-title>
            <source>Pregnancy Hypertens</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>15</volume>
            <fpage>118</fpage>
            <page-range>118-122</page-range>
            <pub-id pub-id-type="pmid">30825907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Role of a quality management system in improving patient safety - laboratory aspects.</article-title>
            <source>Clin Biochem</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>46</volume>
            <issue>13-14</issue>
            <fpage>1187</fpage>
            <page-range>1187-93</page-range>
            <pub-id pub-id-type="pmid">23648455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McKinney</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rotz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wafula</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sendagire</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nkengasong</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Improving quality management systems of laboratories in developing countries: an innovative training approach to accelerate laboratory accreditation.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>401</fpage>
            <page-range>401-9</page-range>
            <pub-id pub-id-type="pmid">20716796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carey</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Bhattacharyya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kehl</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Matukas</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Pentella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Salfinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schuetz</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Practical Guidance for Clinical Microbiology Laboratories: Implementing a Quality Management System in the Medical Microbiology Laboratory.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">29720490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westgard</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: planning and implementation strategies.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>40</volume>
            <issue>Pt 6</issue>
            <fpage>593</fpage>
            <page-range>593-611</page-range>
            <pub-id pub-id-type="pmid">14629798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mrazek</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Keppel</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Felder</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Oberkofler</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Haschke-Becher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cadamuro</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2020</year>
            <month>Jun</month>
            <day>15</day>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>020502</fpage>
            <pub-id pub-id-type="pmid">32550813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Rossum</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Technical quality assurance and quality control for medical laboratories: a review and proposal of a new concept to obtain integrated and validated QA/QC plans.</article-title>
            <source>Crit Rev Clin Lab Sci</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>586</fpage>
            <page-range>586-600</page-range>
            <pub-id pub-id-type="pmid">35758201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinns</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pitkin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Housley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: best practice.</article-title>
            <source>J Clin Pathol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1027</fpage>
            <page-range>1027-32</page-range>
            <pub-id pub-id-type="pmid">24072731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badrick</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Integrating quality control and external quality assurance.</article-title>
            <source>Clin Biochem</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>95</volume>
            <fpage>15</fpage>
            <page-range>15-27</page-range>
            <pub-id pub-id-type="pmid">33965412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liao</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Adjusting Quality Control Chart Limits for WBC, RBC, Hb, and PLT Counts to Reduce Daily Control Risks in Hospital Laboratory.</article-title>
            <source>Risk Manag Healthc Policy</source>
            <year>2020</year>
            <volume>13</volume>
            <fpage>3039</fpage>
            <page-range>3039-3049</page-range>
            <pub-id pub-id-type="pmid">33364865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coskun</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Modified Levey-Jennings charts for calculated laboratory tests.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2006</year>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>387</fpage>
            <page-range>387-90</page-range>
            <pub-id pub-id-type="pmid">16599829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bayat</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Selecting multi-rule quality control procedures based on patient risk.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2017</year>
            <month>Oct</month>
            <day>26</day>
            <volume>55</volume>
            <issue>11</issue>
            <fpage>1702</fpage>
            <page-range>1702-1708</page-range>
            <pub-id pub-id-type="pmid">28236626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Earley</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Astles</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Breckenridge</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Practices and Perceived Value of Proficiency Testing in Clinical Laboratories.</article-title>
            <source>J Appl Lab Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>415</fpage>
            <page-range>415-420</page-range>
            <pub-id pub-id-type="pmid">31903445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nemchin</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Brusick</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Basic principles of laboratory safety.</article-title>
            <source>Environ Mutagen</source>
            <year>1985</year>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>947</fpage>
            <page-range>947-70</page-range>
            <pub-id pub-id-type="pmid">4065066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meisenhelder</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bursik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lunn</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Strober</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Laboratory safety.</article-title>
            <source>Curr Protoc Hum Genet</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>Appendix 2</volume>
            <fpage>Appendix 2A</fpage>
            <pub-id pub-id-type="pmid">18428418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burnett</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Lunn</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coico</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Biosafety: guidelines for working with pathogenic and infectious microorganisms.</article-title>
            <source>Curr Protoc Microbiol</source>
            <year>2009</year>
            <month>May</month>
            <volume>Chapter 1</volume>
            <issue>1</issue>
            <fpage>Unit 1A.1</fpage>
            <pub-id pub-id-type="pmid">19412909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Byrd</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>TV</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis B vaccination coverage among health-care personnel in the United States.</article-title>
            <source>Public Health Rep</source>
            <year>2013</year>
            <season>Nov-Dec</season>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>498</fpage>
            <page-range>498-509</page-range>
            <pub-id pub-id-type="pmid">24179261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ezad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cheema</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction.</article-title>
            <source>Oxf Med Case Reports</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>2018</volume>
            <issue>3</issue>
            <fpage>omx104</fpage>
            <pub-id pub-id-type="pmid">29593874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20105.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fry</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Farrington</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Management of acute renal failure.</article-title>
            <source>Postgrad Med J</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>82</volume>
            <issue>964</issue>
            <fpage>106</fpage>
            <page-range>106-16</page-range>
            <pub-id pub-id-type="pmid">16461473</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
